Suchergebnisse - "Xia, Zhongjun"

PubPharm (5)

1

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11

2

A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: British journal of cancer | 2021

von Cai, J. | Tian, X. | Ma, S. | +15

3

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial : a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

4

Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia : a retrospective single-center study

enthalten in: International journal of hematology | 2019

von Li, C. | Cai, X. | Chen, X. | +3

5

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen : a single-institution experience

enthalten in: Leukemia & lymphoma | 2011

von Huang, H. | Lin, Z. | Lin, X. | +3

1
[1]